Office of the Chief Scientist of Israel - OCS

Summary

The main office of represented Corporate Investor is situated in the Tel Aviv. The company was established in Asia in Israel.

The typical case for the fund is to invest in rounds with 1-2 participants. Despite the Office of the Chief Scientist of Israel - OCS, startups are often financed by Sirius Venture Capital Pte Ltd, SLJ Investment Partners, Global Life Science Ventures. The meaningful sponsors for the fund in investment in the same round are Maayan Ventures, hiCenter Ventures, Oriella PR Network. In the next rounds fund is usually obtained by Oriella PR Network, EASME - EU Executive Agency for SMEs, 500 Startups.

Among the various public portfolio startups of the fund, we may underline Hargol FoodTech, Cell Cure Neurosciences, User1st We can highlight the next thriving fund investment areas, such as AgTech, Medical. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Israel. The fund has no exact preference in some founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little.

Considering the real fund results, this Corporate Investor is 9 percentage points less often commits exit comparing to other organizations. Comparing to the other companies, this Office of the Chief Scientist of Israel - OCS performs on 18 percentage points less the average number of lead investments. The high activity for fund was in 2013. Despite it in 2019 the fund had an activity. The fund is constantly included in less than 2 deals per year. The common things for fund are deals in the range of 100 thousands - 1 million dollars. The increased amount of exits for fund were in 2018.